Clinical trial

Responsiveness to Dalfampridine-ER Treatment Among Multiple Sclerosis Patients

NCT01399957

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2010-08-01

PhaseN/A

Study timeline

Study start (unknown)2010-08-01Date precision: month

Registry last updated2015-11-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

Sponsors & collaborators

Mount Sinai Rehabilitation Hospitallead sponsor

Brown Universitycollaborator

Acorda Therapeuticscollaborator

Mapped research locations

HartfordConnecticut, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01399957 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.